December 19, 2016 — Children’s National Health System and Celsion Corp. announced in November the launch of a clinical ...

Client Outlook, a provider of FDA Class II diagnostic and clinical image viewing solutions, announced recently that Chinese company eimageglobal has selected eUnity as its diagnostic enterprise image viewing platform, and both parties have formed a strategic long-term partnership. Eimageglobal’s physician/patient/scheduling platform won the China National Innovation and Entrepreneurial award this year, and the integration of eUnity allows physicians, healthcare providers and patients to have increased and timely access to critical health information.

December 14, 2016 — Patients undergoing magnetic resonance (MR) exams will find a relaxing environment with Toshiba ...

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that target pivotal enzyme targets on cancer, announced a Phase I clinical trial has commenced in men with high-risk metastatic prostate cancer. In late August, the U.S. Food and Drug Administration cleared CTT’s first Investigational New Drug Application (IND) for a positron emission tomography (PET) imaging agent, CTT1057, labeled with a two-hour half life radiolabel, fluorine-18, and targeting prostate-specific membrane antigen (PSMA).

The American Society for Radiation Oncology (ASTRO) announced in November that Elekta has provided signficant financial support to RO-ILS: Radiation Oncology Incident Learning System a national patient safety initiative launched in 2014 by ASTRO and the American Association of Physicists in Medicine (AAPM). RO-ILS facilitates safer and higher quality care in radiation oncology by providing a mechanism for shared learning in a secure and non-punitive environment. It is the only medical specialty society-sponsored radiation oncology incident learning system within a federally listed Patient Safety Organization (PSO).